ARCT (Arcturus Therapeutics Holdings Inc.) Stock Market Reviews

crown

search

Read and share opinions on ARCT (Arcturus Therapeutics Holdings Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the s

ARCT

Arcturus Therapeutics Holdings Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Arcturus Therapeutics Holdings Inc (ARCT) Q3 2025 Earnings Call Highlights: Navigating ...
Nov 11, 2025
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates
Nov 10, 2025
Arcturus Therapeutics: Q3 Earnings Snapshot
Nov 10, 2025
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
Nov 10, 2025
Arcturus Therapeutics to Attend Upcoming Investor Conferences
Nov 4, 2025
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline
Nov 3, 2025
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Oct 28, 2025
Could ARCT’s Latest CF Trial Data Shift Expectations for Its Pipeline Potential?
Oct 25, 2025
How Recent Shifts Are Rewriting the Story for Arcturus Therapeutics Holdings
Oct 23, 2025
Arcturus Crashes 50% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug
Oct 22, 2025
Zacks.com featured highlights include Flux Power, Aura Minerals, Arcturus Therapeutics and Sterling Infrastructure
Oct 22, 2025
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
Oct 22, 2025

Reviews